Before the discovery of Trofinetide, GPE demonstrated modulatory effects on neurons and certain CNS enzymes (ChAT, GAD, NOS, and tyrosine hydroxylase) and was claimed to treat neurodegenerative diseases [47,48,49,50]. The gene discussed is GYPE; the disease is neurodegenerative disease.